<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03368352</url>
  </required_header>
  <id_info>
    <org_study_id>170200</org_study_id>
    <nct_id>NCT03368352</nct_id>
  </id_info>
  <brief_title>Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.</brief_title>
  <official_title>Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low oxygen at altitude causes pauses in breathing during sleep, called central sleep apnea.
      Central sleep apnea causes repeated awakenings and poor sleep. Low oxygen itself and the
      induced oxidative stress can damage mental function which is likely worsened by poor sleep.
      Reduced mental function due to low oxygen can pose a serious danger to mountain climbers.
      However there is also mounting evidence that even in populations of people that live at high
      altitudes and are considered adapted, low oxygen contributes to reductions in learning and
      memory. Therefore there is a serious need for treatments which may improve sleep, control of
      breathing and mental function during low oxygen. Melatonin is a hormone produced in the brain
      during the night which regulates sleep patterns with strong antioxidant and anti-inflammatory
      properties. A study previously reported that melatonin taken 90 mins before bed at 4,300 m
      (14,200 ft) induced sleep earlier, reduced awakenings and improved mental performance the
      following day. However how melatonin caused these effects was not determined. Therefore this
      study aims to determine how melatonin effects control of breathing, sleep and mental
      performance during exposure to low oxygen.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 4, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized, double-blind, placebo controlled</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neurocognitive function</measure>
    <time_frame>30 minutes after arousal from sleep</time_frame>
    <description>Stroop-color word test median number of errors. Higher numbers indicate worse performance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>5 minutes after arousal from sleep</time_frame>
    <description>Reactive hypermedia index via EndoPat</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lipid peroxidation in serum</measure>
    <time_frame>immediately after arousal from sleep</time_frame>
    <description>Concentration of Malondialdehyde in serum samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hypercapnic hypoxic ventilatory sensitivity</measure>
    <time_frame>1 hour after arousal from sleep</time_frame>
    <description>This is the one outcome. It is the gain of the ventilatory response to changes in CO2, during sustained hypoxia. Delta minute ventilation / delta mmHg CO2 during sustained hypoxia</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Altitude Hypoxia</condition>
  <condition>Ventilation</condition>
  <condition>Sleep</condition>
  <condition>Oxidative Stress</condition>
  <condition>Neurocognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>Normoxia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Sleep in normal room air with no drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoxia with Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sleep in hypoxic tent after taking Placebo 1 hour before bed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypoxia with Melatonin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sleep in hypoxic tent after taking 5 mg Melatonin before bed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <description>Dietary supplement melatonin</description>
    <arm_group_label>Hypoxia with Melatonin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hypoxia</intervention_name>
    <description>Sleep in a hypoxic tent simulating high altitude</description>
    <arm_group_label>Hypoxia with Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Exclusion Criteria:

          -  Sleep disorders

          -  Pregnant females

          -  Smokers (quit â‰¥ 1 year ago acceptable)

          -  Any known cardiac (apart from treated hypertension with acceptable drugs, see below),
             pulmonary (including asthma), renal, neurologic (including epilepsy), neuromuscular,
             hepatic disease, or patients with diabetes.

          -  Prior or current use of melatonin.

          -  Use of any medications that may affect sleep or breathing, blood-thinning medications
             (anticoagulants), antioxidants, anti-inflammatories, medications that suppress the
             immune system (immunosuppressants), diabetes medications and birth control pills.

          -  A psychiatric disorder, other than mild depression; e.g. schizophrenia, bipolar
             disorder, major depression, panic or anxiety disorders.

          -  Substantial alcohol (&gt;3oz/day) or use of illicit drugs.

          -  Previous occurrence of high altitude pulmonary or cerebral edema.

          -  Recent exposure to altitude (&gt;8000ft) in the last month or having slept at an altitude
             &gt;6000ft in the last month.

          -  Inability to provide written informed consent or able to complete the experiment.

          -  Non-English speakers (necessary to complete neurocognitive testing).

          -  More than 10 cups of beverages with caffeine (coffee, tea, soda/pop) per day.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Naomi Deacon, PhD</last_name>
    <phone>619-471-9484</phone>
    <email>Ndeacon@ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCSD Sleep Lab</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Naomi L Deacon, PhD</last_name>
      <phone>619-471-9484</phone>
      <email>ndeacon@ucsd.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nana Bosompra, BA</last_name>
      <phone>(858) 246-2154</phone>
      <email>sleepresearch@ucsd.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Atul Malhotra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank Powell, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tatum Simonson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Naomi Deacon, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stacie Moore, RRT-SDS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria R Powell, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dillon Gillbertson, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pamela DeYoung, RPSGT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Owens, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeremy Orr, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janelle Fine, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Naa-Oye Bosompra, BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2017</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Naomi Deacon</investigator_full_name>
    <investigator_title>Research Scholar</investigator_title>
  </responsible_party>
  <keyword>Melatonin</keyword>
  <keyword>Altitude</keyword>
  <keyword>Sleep</keyword>
  <keyword>Ventilation</keyword>
  <keyword>Cognition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

